A detailed history of Jump Financial, LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Jump Financial, LLC holds 74,957 shares of TARS stock, worth $3.68 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
74,957
Holding current value
$3.68 Million
% of portfolio
0.05%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$21.54 - $34.6 $1.61 Million - $2.59 Million
74,957 New
74,957 $2.47 Million
Q1 2024

May 13, 2024

BUY
$19.61 - $39.22 $577,906 - $1.16 Million
29,470 New
29,470 $1.07 Million
Q3 2022

Nov 07, 2022

SELL
$14.08 - $18.5 $164,736 - $216,450
-11,700 Reduced 48.75%
12,300 $211,000
Q2 2022

Aug 09, 2022

BUY
$11.08 - $19.08 $265,920 - $457,919
24,000 New
24,000 $350,000

Others Institutions Holding TARS

About Tarsus Pharmaceuticals, Inc.


  • Ticker TARS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,658,500
  • Market Cap $1.31B
  • Description
  • Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...
More about TARS
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.